[Interpretation and analysis of the testing results of main molecular pathological markers in breast cancer]

Y L Yang1, X J Guo1, L Fu1

  • 1Tianjin Medical University Cancer Institute and Hospital; National Clinical Research Center of Cancer; Key Laboratory of Cancer Prevention and Therapy; Tianjin's Clinical Research Center for Cancer; Key Laboratory of Breast Cancer Prevention and Theraphy, Ministry of Education, Tianjin 300060, China.

Abstract

No abstract available in PubMed .